- Celiac disease testing is crucial for the diagnosis of celiac disease, an autoimmune disorder triggered by gluten consumption. These tests help detect the presence of antibodies in the blood, as well as genetic markers, to confirm the diagnosis
- The demand for celiac disease testing is significantly driven by the increasing awareness of the disease, better understanding of its symptoms, and rising prevalence across global populations
- North America is expected to dominate the celiac disease testing market due to advanced healthcare infrastructure, widespread awareness, and the high availability of diagnostic technologies
- Asia-Pacific is projected to be the fastest growing region in the celiac disease testing market due to increasing healthcare awareness, growing incidences of autoimmune disorders, and expanding access to diagnostic services
- Serology tests segment is expected to dominate the global celiac disease testing market with a market share of approximately 60.5%. This dominance is attributed to the high demand for precision in diagnosing celiac disease, along with the increasing use of serology rapid testing kits. These tests remain the most common and effective method for detecting celiac disease due to their ability to detect antibodies in the blood, contributing significantly to the market's growth
